A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)

Clinical trial NCT00514917 · TERMINATED

Trial details

NCT number: NCT00514917
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2007-07-01
Primary completion: 2012-09-01
Enrollment: 413

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.